![Graham Bell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Dr. Bell joined us in November 1998 as Project Manager and has served as General Manager, Polgen Division since 2000.
He was previously Head of Cell Culture with Biocure Ltd.
(now Medysis plc) a biotech company spun out of Aberdeen University.
He holds a B.Sc.
and Ph.D.
from Edinburgh University.
Anciens postes connus de Graham Bell
Sociétés | Poste | Fin |
---|---|---|
Cyclacel Group Plc
![]() Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Corporate Officer/Principal | 15/10/2008 |
Formation de Graham Bell
The University of Edinburgh | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Cyclacel Group Plc
![]() Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Health Technology |